/ARTLW

ARTLW Stock - Artelo Biosciences, Inc.

Q: What is the analyst price target for ARTLW?

Analyst price target information is not currently available for ARTLW.

Q: What is ARTLW's market cap?

Market capitalization information is not currently available for ARTLW.

Healthcare|Biotechnology|NASDAQ

$0.01+0.00%

+$0.00 (+0.00%) • Jun 17

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.01

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ARTLW

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.25

52W High$0.01

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-10,108,000	$-9,930,000	$-10,287,000	$-7,441,000	$-4,686,000
Net Income	$-9,826,000	$-9,289,000	$-10,083,000	$-7,437,000	$-4,655,000
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-3.05	$-3.14	$-3.49	$-5.97	$-18.83

Company Overview

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Visit Website

Earnings History & Surprises

ARTLW

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.56

Q2 2023

EPS Surprise History

Q4 22

No data

Q1 23

No data

Q2 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2023	Jun 30, 2023	—	$-0.56	—	—
Q1 2023	Mar 31, 2023	—	$-0.72	—	—
Q4 2022	Dec 31, 2022	—	$-1.13	—	—

Frequently Asked Questions about ARTLW

What is ARTLW's current stock price?

Artelo Biosciences, Inc. (ARTLW) is currently trading at $0.01 per share. The stock has moved +0.00% today.

What is the analyst price target for ARTLW?

No analyst price targets are currently available for this stock.

What sector is Artelo Biosciences, Inc. in?

Artelo Biosciences, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.

What is ARTLW's market cap?

Artelo Biosciences, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does ARTLW pay dividends?

No, Artelo Biosciences, Inc. does not currently pay a dividend to shareholders.